This article was originally published in The Gray Sheet
Executive SummaryIn a Jan. 21 letter to Commissioner David Kessler, Rep. Edolphus Towns (D-N.Y.) asks FDA to brief the staff of his House Government Operations/Human Resources Subcommittee "on or about" Feb. 11 "on all FDA activities associated with [temporomandibular joint] implants conducted since the subcommittee's hearing that was held on June 4, 1992 and on all current and planned FDA activities associated with TMJ implants." In October, subcommittee staffers said that followup of TMJ-related issues was a "top priority" for Towns ("The Gray Sheet" Oct. 18, In Brief). The panel's investigation focuses on health hazards associated with TMJ implants
You may also be interested in...
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.